In Huntington Disease, 2 Biomarkers Track Striatal Atrophy in Opposite Directions Two biomarkers, NfL and TNFRSF8, show opposite associations with putamen volume in HD, suggesting a dual-pathology model of striatal atrophy.

An ultrasensitive cerebrospinal fluid (#CSF) proteomic analysis using the Next-Gen Ultra-Sensitive Immunoassay (#NULISA™) platform identified a dual-pathology model underlying striatal degeneration in #HuntingtonDisease.

Learn more: https://bit.ly/4ulLwgg

#RareDisease #MedSky

Proud to join the #ARGOnaut Club! Sapient is among the first to bring Alamar Biosciences' ARGO HT + NULISA in house to measure key cytokine/chemokine targets in #inflammation + #CNS. Meet our system “Phocus”! Want to learn more? Reach out. #proteinbiomarkers #NULISA #ARGOHT #cytokines

Alamar Biosciences Unveils Groundbreaking Tau Protein Data at AAIC 2025 Conference Alamar Biosciences showcases innovative tau protein research at the Alzheimer's Association International Conference 2025, revealing critical insights into neurodegenerative diseases.

Alamar Biosciences Unveils Groundbreaking Tau Protein Data at AAIC 2025 Conference #USA #Toronto #Alamar_Biosciences #NULISA #tau_proteins

Alamar Biosciences Unveils Groundbreaking Brain-Derived Tau Data at AAIC 2025 Alamar Biosciences makes a significant impact at the AAIC 2025 with pioneering data on brain-derived tau proteins, highlighting advancements in early disease detection.

Alamar Biosciences Unveils Groundbreaking Brain-Derived Tau Data at AAIC 2025 #USA #Toronto #Alamar_Biosciences #NULISA #Tau_Protein

Alamar Biosciences Unveils Groundbreaking pTau Data at AAIC Conference Alamar Biosciences announces pioneering pTau data derived from the brain at the Alzheimer's Association International Conference, showcasing its innovative NULISA platform in detecting neurodegenerative diseases.

Alamar Biosciences Unveils Groundbreaking pTau Data at AAIC Conference #Canada #Toronto #Alamar_Biosciences #NULISA #pTau

Alamar Biosciences Unveils Groundbreaking pTau Research at AAIC 2025 Explore Alamar Biosciences' innovative presentation of pTau data aimed at transforming Alzheimer’s diagnostics at AAIC 2025 in Toronto.

Alamar Biosciences Unveils Groundbreaking pTau Research at AAIC 2025 #Canada #Toronto #Alamar_Biosciences #NULISA #pTau

🧠 We'll be at #AAIC2025 in Toronto, July 27–31! We support precision neuroscience with multiomics solutions for biomarker discovery, including Alamar's ARGO™ HT & NULISA™ for ultrasensitive proteomics, Booth #1516!
@alzassociation.bsky.social
#proteomics #multiomics #NULISA #Neurodegeneration

We are proud to announce our strategic partnership with Alamar Biosciences as a Certified Service Provider for their ultra-sensitive #NULISA platform.🤝

Learn more about the NULISA assays here: biognosys.com/nulisa-multi...

#BiomarkerDiscovery #PlasmaBiomarkers

Alamar Biosciences Enhances Access to NULISA Technology with Certified Service Provider Program Alamar Biosciences has launched a Certified Service Provider Program to broaden access to its advanced NULISA technology for researchers in academia and biopharmaceutical sectors.

Alamar Biosciences Enhances Access to NULISA Technology with Certified Service Provider Program #USA #Fremont #Alamar_Biosciences #NULISA #Biomarker_Detection

Alamar Biosciences Introduces New Program to Broaden NULISA Technology Access for Researchers Alamar Biosciences has launched its Certified Service Provider Program, enhancing access to NULISA technology for academic and biopharmaceutical research. The initiative aims to support groundbreaking discoveries.

Alamar Biosciences Introduces New Program to Broaden NULISA Technology Access for Researchers #USA #Fremont,_California #Alamar_Biosciences #NULISA #Certified_Service_Provider

Start your day at #USHUPO2025 with our Breakfast Symposium on Feb 25, 7:15-8:15 am: Ultra-Sensitive Detection of Plasma Cytokines & Chemokines with the #NULISA Platform. Visit us at Booth #14! alamarbio.com/us-hup... #USHUPOSponsor #SponsoredPost #Proteomics

Join us on Feb 25, 7:15-8:15 am for a Breakfast Symposium on Ultra-Sensitive Detection of Plasma Cytokines & Chemokines with experts Hanno Steen, PhD (Harvard) & Yuehan Feng, PhD (Biognosys). Don’t miss it! #NULISA #USHUPOSponsor #SponsoredPost alamarbio.com/us-hup...